Search Results for: Sanofi Alnylam Enter Into Strategic
Articles
January 8, 2018
Sanofi & Alnylam Enter Into Strategic Restructuring of RNAi Therapeutics Rare Disease Alliance January 8, 2018
Sanofi and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today a strategic restructuring of their RNAi...
September 15, 2020
Novus Announces Acquisition of Anelixis September 15, 2020
Novus Therapeutics, Inc. recently announced it has completed the acquisition of Anelixis Therapeutics, Inc., a privately held clinical-stage biotechnology company developing a next-generation….
November 8, 2012
11/14/2012 November 8, 2012
A Note to The Pharmaceutical Industry Upon The Re-Election of Barack Obama By: Matthew Herper, Forbes Staff, mherper@forbes.com I've covered...
August 20, 2012
8/22/2012 August 20, 2012
United Drug Acquires Leading Clinical Trials Materials Business United Drug plc recently announced it has reached an agreement to acquire...
April 19, 2011
4/26/2011 April 19, 2011
Precision NanoSystems & Alnylam Form New Delivery Collaboration Precision NanoSystems, Inc. and Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company,...
